作者: Ursula Grohmann , Francesca Fallarino , Roberta Bianchi , Maria Laura Belladonna , Carmine Vacca
DOI: 10.4049/JIMMUNOL.167.2.708
关键词:
摘要: The outcome of dendritic cell (DC) presentation tumor and/or self peptides, including P815AB (a peptide murine mastocytoma cells) and NRP-A7 synthetic mimotope recognized by diabetogenic T cells), may depend on a balance between the activities immunogenic (CD8α−) tolerogenic (CD8α+) DC. By virtue their respective actions CD8− CD8+ DC, IL-12 IFN-γ have functionally opposing effects DC subset, IFN-γ-activated mediate that prevail over adjuvant activity We previously shown CD40 ligation abrogates potential an effect associated with impaired capacity CD40-modulated IFN-γ-treated to degrade tryptophan initiate apoptosis in vitro. report here IL-6 both replace (upon administration recombinant cytokine) (as assessed use neutralizing Abs) ablating includes down-regulation IFN-γR expression subset correlates reduced ability these cells metabolize